Company Encyclopedia
View More
name
Health Care Select Sector SPDR
XLV.US
News
View More

UNH Stock In 2026: Bull And Bear Case Scenarios

The article analyzes UnitedHealth's stock outlook for 2026, focusing on the Medical Care Ratio (MCR) impact on profitability. It presents three scenarios: stabilization, recovery, and further deterioration, each affecting EPS and share price. Key assumptions include premium revenue, baseline MCR, EPS, and Optum earnings. The article also suggests the High Quality Portfolio for less volatile returns.

Forbes·
US
UNH
-1.83%
Forbes·
US
UNH
-1.83%

Mirabella Financial Services LLP Has $2.41 Million Position in AbbVie Inc. $ABBV

Mirabella Financial Services LLP reduced its stake in AbbVie Inc. by 69.5% in Q2, owning 12,919 shares worth $2.41 million. Other institutional investors adjusted their positions in AbbVie. Analysts have varied ratings, with a consensus of "Moderate Buy" and a target price of $241.85. AbbVie reported Q3 earnings of $1.86 EPS, beating estimates, and increased its dividend to $1.73 per share. The stock opened at $228.68, with a market cap of $404.17 billion.

Market Beat·
US
ABBV
-0.66%
Market Beat·
US
ABBV
-0.66%

Assessing Abbott After 10.5% Gains and DCF PE Signals Amid Exact Sciences Deal Talk

Abbott Laboratories' stock is up 10.5% year-to-date, but a DCF analysis suggests it's overvalued by 72.1%, with intrinsic value at $72.88 per share versus current $125.40. However, its PE ratio of 15.7x is below industry averages, indicating undervaluation. The stock's valuation is mixed, with DCF showing overvaluation and PE suggesting undervaluation. Investors should consider narratives for a holistic view.

Simplywall·
US
ABT
+0.09%
Simplywall·
US
ABT
+0.09%

First Trust Advisors LP Sells 21,347 Shares of Amgen Inc. $AMGN

First Trust Advisors LP reduced its stake in Amgen Inc. by 3.8% in Q2, selling 21,347 shares. Amgen's stock opened at $340.16, with a market cap of $183.17 billion. The company reported Q3 earnings of $5.64 per share, beating estimates, and announced a quarterly dividend of $2.38. Insiders sold shares, including EVP Murdo Gordon and SVP Rachna Khosla.

Market Beat·
US
AMGN
-1.52%
Market Beat·
US
AMGN
-1.52%

AbbVie-Sponsored Symposium at ESMO Asia 2025 Highlights Urgent Medical Need in Platinum-Resistant Advanced Ovarian Cancer

An AbbVie-sponsored symposium at ESMO Asia 2025 addressed the critical need for new strategies to define and treat platinum resistance in advanced ovarian cancer. Experts highlighted that platinum-resistant advanced ovarian cancer has a poor prognosis and current treatment options are limited and often accompanied by significant side effects, affecting patients' quality of life. The discussion emphasized exploring novel approaches, including Antibody Drug Conjugates (ADCs), to improve efficacy, tolerability, and patient outcomes in this challenging disease.

PR Newswire·
US
ABBV
-0.66%
PR Newswire·
US
ABBV
-0.66%
Posts
View More

three green sectors $SPDR FD Consumer Staples(XLP.US) $Health Care Select Sector SPDR(XLV.US) $Real Est Select Spdr(XLRE.US)

Source: Sunrise Trader

S&P 500 cap weighted sectors that are green right now in this order $Select Sect Spdr Util(XLU.US) $Comm Servcies Select Sector SPDR(XLC.US) $Health Care Select Sector SPDR(XLV.US) $Spdr Select Indu(X............

© 2025 Longbridge｜Disclaimer